There were 19 press releases posted in the last 24 hours and 161,508 in the last 365 days.

Autism R&D Pipeline Analysis Report, H2-2018 Therapeutics Review

/EIN News/ -- Dublin, Jan. 18, 2019 (GLOBE NEWSWIRE) -- The "Autism R&D Pipeline Analysis Report, H2-2018" report has been added to's offering.

The Autism pipeline guide presents complete overview of drugs currently being developed for Autism. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials).

Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Autism pipeline candidate.
Research and Development progress along with latest news related to each of the Autism pipeline candidates is included.

Major companies participating in therapeutic development of Autism are included in this pipeline report. Company wise pre clinical and clinical products along with details of drug originator, co developers/ licensors are provided.

Amid strong interest for cure of Autism from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Autism clinical and pre clinical products.

The report assists in identifying potential upcoming companies and drugs in Autism pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition.

Key Topics Covered:

I. Key Findings

1. Companies Investing in Autism Pipeline include
Number of Companies with Autism projects in pre clinical Development
Number of Companies with Autism projects in Clinical Development
Autism Pipeline Companies based in Americas
Autism Pipeline Companies based in Europe
Autism Pipeline Companies based in Asia Pacific
Autism Pipeline Companies based in Rest of the World

2. Pipeline Candidates include
Autism Pipeline Agents in pre clinical/ Discovery stage of Development
Autism Pipeline Agents in Clinical Development stage
Autism Pipeline Therapeutic Compounds received special status
Mechanism of Action of most pipeline Drugs
Small molecules among the Autism Pipeline agents

II. Insights into Autism Pipeline -

1. Disease Overview
Introduction to Autism
Symptoms and Causes of Autism
Treatment or Prevention Options for Autism
Other Details
2. Phase wise Pipeline Compounds
Autism Pipeline Pre Clinical/ Discovery stage Drugs
Autism Pipeline Phase 1 stage Drugs
Autism Pipeline Phase 2 stage Drugs
Autism Pipeline Phase 3 stage Drugs
Autism Pipeline Pre Registration stage Drugs
3. Company wise Autism Pipeline Compounds
4. Autism Pipeline by Mechanism of Action

III. Autism Pipeline Compound Details

Drug Details

1. Snapshot
Name of the Therapeutic Agent
Developing Company
Co Developer/ License Partner
Orphan Drug / Fast Track/ Designation
Development Phase
2. Drug Overview
3. Mechanism of Action
4. Current Status
5. Clinical Trial Details

IV. Autism Pipeline Company Briefs

V. Latest News and Developments in Global Autism Pipeline Market

VI. Appendix

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

         Laura Wood, Senior Press Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Central Nervous System Drugs 


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.